West Boca Medical Center Opens New Interventional Vascular Imaging Suite

West Boca Medical Center increases its services in the community by offering patients advanced vascular and interventional imaging procedures in its new imaging suite and interventional radiology lab.

The new lab will add the Siemens Artis Q system to enhance imaging and invasive services. The system features high-resolution capabilities, which enhance minimally invasive therapies for peripheral vascular disease, embolization, and diagnostic examination.

“We are excited to bring this enhanced level of interventional and vascular capabilities to our patients that can be accessed right here in their community,” said George Rizzuto, chief executive officer of West Boca Medical Center.  “Our first priority is to deliver the highest quality and safest treatments to our patients.  These services and this new lab demonstrates our commitment by continuing to bring the most current technology and resources to Palm Beach County.”

Some of the benefits of this new technology include:

  • Superior image quality that provides better visualization of small vessels, devices, and tissue.
  • Enhanced system efficiency to produce the highest image quality at the lowest possible doses.
  • Improved interventional imaging for treatment of peripheral vascular disease.
  • Ability to perform rotational imaging for 3D reconstruction and vascular road mapping.
  • Integration of other imaging modalities, including CT and ultrasound, that provides a basis for planning therapies, such as embolization of tumors.

This $4 million dollar investment will allow West Boca Medical Center to partner with sister hospital Delray Medical Center to expand its vascular services and offer patients this specialized care and technology in the community.  For more information go to www.westbocamedctr.com or call 561-488-8000.

 

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

Tabrecta is the first FDA-approved therapy to treat non small cell lung cancer with specific mutations (those that lead to mesenchymal-epithelial transition or MET exon 14 skipping).
The Cor® TRICUSPID ECM® valve has been successfully implanted in the 11th patient enrolled in the expansion by Dr. Marc Gerdisch, Chief of Cardiothoracic Surgery at Franciscan Health Heart Center in Indianapolis, Indiana & principal investigator for the adult component of the study.
Thirona notes LungQ 3.0.0 builds on 10 years of clinical trials and 200+ publications to deliver advanced segmentation of pulmonary segments and subsegments.
The Zeta Surgical Cranial Navigation System is a mixed-reality navigation system for neurosurgery, providing surgeons with "GPS-like" guidance with millimetric accuracy in real-time. Zeta's computer vision engine ensures maintained accuracy by automatically registering multiple times a second, accounting for patient movement, and allowing for awake and non-immobilized use in both operative and extra-operative settings.
The updated ZEISS femtosecond laser provides U.S. refractive surgeons with faster treatment, greater flexibility, and significant workflow enhancements.

By using this website you agree to accept Medical Device News Magazine Privacy Policy